ReviewWiener medizinische Wochenschrift (1946)2025
Nodular morphea on the breast of a pregnant woman-case report and literature review.
Review in Wiener medizinische Wochenschrift (1946), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nodular lesions on the breast can be alarming for women and have a negative physical and psychological impact. The lesions might be underdiagnosed as keloid or overdiagnosed as malignancies. To reach an accurate diagnosis, pathological examination is required. We herein present a case of linear keloidal morphea on the breast of a 30-year-old woman who presented with a firm asymptomatic lesion that developed during pregnancy. She had a family history of autoimmune diseases. Careful clinical and dermoscopic investigations with histopathological examination were consistent with nodular morphea. In addition, we analyze reports of nodular morphea from the past 25 years. The most common comorbidities of nodular morphea are systemic sclerosis, systemic lupus erythematosus, and morphea (localized scleroderma). Treatment is a challenge.
Indexed as
Identifiers
40742658What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.